References
- Cuschieri S, Grech S. Obesity population at risk of COVID-19 complications. Glob Health Epidemiol Genom 2020;5:e6. doi: 10.1017/gheg.2020.6
- Wiemers EE, Abrahams S, AlFakhri M, Hotz VJ, Schoeni RF, Seltzer JA. Disparities in vulnerability to complications from COVID-19 arising from disparities in preexisting conditions in the United States. Res Soc Stratif Mobil 2020;69:100553. doi: 10.1016/j.rssm.2020.100553
- Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med 2020;38:1504–7. doi: 10.1016/j.ajem.2020.04.048
- Kunutsor SK, Laukkanen JA. Renal complications in COVID-19: a systematic review and meta-analysis. Ann Med 2020;52:345–53. doi: 10.1080/07853890.2020.1790643
- Rashedi J, Mahdavi Poor B, Asgharzadeh V, Pourostadi M, Samadi Kafil H, Vegari A, Tayebi-Khosroshahi H, Asgharzadeh M. Risk factors for COVID-19. Infez Med 2020;28:469–74. PMID: 33257620
- Zeng H, Yang Q, Yuan P, Wang X, Cheng L. Associations of essential and toxic metals/metalloids in whole blood with both disease severity and mortality in patients with COVID-19. FASEB J 2021;35(3):e21392. doi: 10.1096/fj.202002346RR
- Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection 2021;49:15–28. doi: 10.1007/s15010-020-01509-1
- Skalny AV, Lima TRR, Ke T, Zhou JC, Bornhorst J, Alekseenko SI, Aaseth J, Anesti O, Sarigiannis DA, Tsatsakis A, Aschner M, Tinkov AA. Toxic metal exposure as a possible risk factor for COVID-19 and other respiratory infectious diseases. Food Chem Toxicol 2020;146:111809. doi: 10.1016/j.fct.2020.111809
- Nordberg GF, Costa M, editors. Handbook on the Toxicology of Metals. Volume I and II. 5th ed. New York (NY): Academic Press; 2022.
- ATSDR. ATSDR’s Substance Priority List, 2022 [displayed 27 May 2024]. Available at
https://www.atsdr.cdc.gov/spl/index.html - International Agency for Research on Cancer (IARC). Arsenic and arsenic compounds. In: Arsenic, metals, fibres, and dusts. Volume 100C. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC; 2012. p. 41–93.
- International Agency for Research on Cancer (IARC). Chromium (VI) compounds. In: Arsenic, metals, fibres, and dusts. Volume 100C. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC; 2012. p. 147–68.
- International Agency for Research on Cancer (IARC). Cadmium and cadmium compounds. In: Arsenic, metals, fibres, and dusts. Volume 100C. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC; 2012. p. 121–45.
- International Agency for Research on Cancer (IARC). Nickel and nickel compounds. In: Arsenic, metals, fibres, and dusts. Volume 100C. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC; 2012. p. 169–218.
- Harris SM, Jin Y, Loch-Caruso R, Padilla IY, Meeker JD, Bakulski KM. Identification of environmental chemicals targeting miscarriage genes and pathways using the comparative toxicogenomics database. Environ Res 2020;184:109259. doi: 10.1016/j.envres.2020.109259
- Baralić K, Živančević K, Božić D, Jennen D, Buha Djordjevic A, Antonijević Miljaković E, Đukić-Ćosić D. Potential genomic biomarkers of obesity and its comorbidities for phthalates and bisphenol A mixture: In silico toxicogenomic approach. BIOCELL 2022;46:519–33. doi: 10.32604/biocell.2022.018271
- Davis AP, Murphy CG, Saraceni-Richards CA, Rosenstein MC, Wiegers TC, Mattingly CJ. Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical-gene-disease networks. Nucleic Acids Res 2009;37(Database issue):D786–92. doi: 10.1093/nar/gkn580
- Wiegers TC, Davis AP, Cohen KB, Hirschman L, Mattingly CJ. Text mining and manual curation of chemical-gene-disease networks for the Comparative Toxicogenomics Database (CTD). BMC Bioinformatics 2009;10:326. doi: 10.1186/1471-2105-10-326
- Montojo J, Zuberi K, Rodriguez H, Bader GD, Morris Q. GeneMANIA: Fast gene network construction and function prediction for Cytoscape. F1000Res 2014;3:153. doi: 10.12688/f1000research.4572.1
- Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, Maitland A, Mostafavi S, Montojo J, Shao Q, Wright G, Bader GD, Morris Q. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 2010;38(Web Server issue):W214–20. doi: 10.1093/nar/gkq537
- Zuberi K, Franz M, Rodriguez H, Montojo J, Lopes CT, Bader GD, Morris Q. GeneMANIA Prediction Server 2013 Update. Nucleic Acids Res 2013;41(Web Server issue):W115–22. doi: 10.1093/nar/gkt533
- Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 2009;37(Web Server issue):W305–11. doi: 10.1093/nar/gkp427
- Landvik NE, Hart K, Skaug V, Stangeland LB, Haugen A, Zienolddiny S. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer. Carcinogenesis 2009;30:1186–92. doi: 10.1093/carcin/bgp122
- Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, Oltolini C, Castiglioni B, Tassan Din C, Boffini N, Tomelleri A, Farina N, Ruggeri A, Rovere-Querini P, Di Lucca G, Martinenghi S, Scotti R, Tresoldi M, Ciceri F, Landoni G, Zangrillo A, Scarpellini P, Dagna L. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol 2020;2(6):e325–31. doi: 10.1016/S2665-9913(20)30127-2
- Thomson EM, Williams A, Yauk CL, Vincent R. Overexpression of tumor necrosis factor-α in the lungs alters immune response, matrix remodeling, and repair and maintenance pathways. Am J Pathol 2012;180:1413–30. doi: 10.1016/j.ajpath.2011.12.020
- Robinson PC, Richards D, Tanner HL, Feldmann M. Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment. Lancet Rheumatol 2020;2(11):e653–5. doi: 10.1016/S2665-9913(20)30309-X
- Huaux F, Louahed J, Hudspith B, Meredith C, Delos M, Renauld JC, Lison D. Role of interleukin-10 in the lung response to silica in mice. Am J Respir Cell Mol Biol 1998;18:51–9. doi: 10.1165/ajrcmb.18.1.2911
- Chen H, Liu W, Wang Y, Liu D, Zhao L, Yu J. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients. EBioMedicine 2021;70:103500. doi: 10.1016/j.ebiom.2021.103500
- Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C, Xia Y. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microb Infect 2020;9:1123–30. doi: 10.1080/22221751.2020.1770129
- Polidoro RB, Hagan RS, De Santis Santiago R, Schmidt NW. Overview: systemic inflammatory response derived from lung injury caused by SARS-CoV-2 infection explains severe outcomes in COVID-19. Front Immunol 2020;11:1626. doi: 10.3389/fimmu.2020.01626
- Jain R, Ramaswamy S, Harilal D, Uddin M, Loney T, Nowotny N, Alsuwaidi H, Varghese R, Deesi Z, Alkhajeh A, Khansaheb H, Alsheikh-Ali A, Abou Tayoun A. Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes. Comput Struct Biotechnol J 2021;19:153–60. doi: 10.1016/j.csbj.2020.12.016
- Chatterjee SK, Saha S, Munoz MNM. Molecular pathogenesis, immunopathogenesis and novel therapeutic strategy against COVID-19. Front Mol Biosci 2020;7:196. doi: 10.3389/fmolb.2020.00196
- Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994;76:253–62. doi: 10.1016/0092-8674(94)90333-6
- Mangalmurti N, Hunter CA. Cytokine storms: understanding COVID-19. Immunity 2020;53:19–25. doi: 10.1016/j.immuni.2020.06.017
- Maxwell AJ, Ding J, You Y, Dong Z, Chehade H, Alvero A, Mor Y, Draghici S, Mor G. Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients. J Leukoc Biol 2021;109:35–47. doi: 10.1002/JLB.4COVR0920-552RR
- Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science 2020;368:473–4. doi: 10.1126/science.abb8925
- Dong Y, Li Z, Ding S, Liu S, Tang Z, Jia L, Liu J, Liu Y. HIV infection and risk of COVID-19 mortality: A meta-analysis. Medicine (Baltimore) 2021;100(26):e26573. doi: 10.1097/MD.0000000000026573
- Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, Du P. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep 2021;11(1):6283. doi: 10.1038/s41598-021-85359-3
- Zawawi A, Alghanmi M, Alsaady I, Gattan H, Zakai H, Couper K. The impact of COVID-19 pandemic on malaria elimination. Parasite Epidemiol Control 202;11:e00187. doi: 10.1016/j.parepi.2020.e00187
- Hussein MIH, Albashir AAD, Elawad OAMA, Homeida A. Malaria and COVID-19: unmasking their ties. Malar J 2020;19(1):457. doi: 10.1186/s12936-020-03541-w
- Davis AP, Murphy CG, Rosenstein MC, Wiegers TC, Mattingly CJ. The Comparative Toxicogenomics Database facilitates identification and understanding of chemical-gene-disease associations: arsenic as a case study. BMC Med Genomics 2008;1:48. doi: 10.1186/1755-8794-1-48